448 related articles for article (PubMed ID: 9721099)
1. Reversal of phencyclidine effects by a group II metabotropic glutamate receptor agonist in rats.
Moghaddam B; Adams BW
Science; 1998 Aug; 281(5381):1349-52. PubMed ID: 9721099
[TBL] [Abstract][Full Text] [Related]
2. A new route to treating schizophrenia?
Wickelgren I
Science; 1998 Aug; 281(5381):1264-5. PubMed ID: 9735037
[No Abstract] [Full Text] [Related]
3. Activation of glutamate neurotransmission in the prefrontal cortex sustains the motoric and dopaminergic effects of phencyclidine.
Takahata R; Moghaddam B
Neuropsychopharmacology; 2003 Jun; 28(6):1117-24. PubMed ID: 12700703
[TBL] [Abstract][Full Text] [Related]
4. Corticolimbic dopamine neurotransmission is temporally dissociated from the cognitive and locomotor effects of phencyclidine.
Adams B; Moghaddam B
J Neurosci; 1998 Jul; 18(14):5545-54. PubMed ID: 9651235
[TBL] [Abstract][Full Text] [Related]
5. The metabotropic glutamate 2/3 receptor agonists LY354740 and LY379268 selectively attenuate phencyclidine versus d-amphetamine motor behaviors in rats.
Cartmell J; Monn JA; Schoepp DD
J Pharmacol Exp Ther; 1999 Oct; 291(1):161-70. PubMed ID: 10490900
[TBL] [Abstract][Full Text] [Related]
6. mGluR2/3 agonist LY379268 rescues NMDA and GABAA receptor level deficits induced in a two-hit mouse model of schizophrenia.
Engel M; Snikeris P; Matosin N; Newell KA; Huang XF; Frank E
Psychopharmacology (Berl); 2016 Apr; 233(8):1349-59. PubMed ID: 26861891
[TBL] [Abstract][Full Text] [Related]
7. N-Methyl-d-aspartate Modulation of Nucleus Accumbens Dopamine Release by Metabotropic Glutamate Receptors: Fast Cyclic Voltammetry Studies in Rat Brain Slices in Vitro.
Yavas E; Young AM
ACS Chem Neurosci; 2017 Feb; 8(2):320-328. PubMed ID: 28121123
[TBL] [Abstract][Full Text] [Related]
8. Effects of N-acetylaspartylglutamate (NAAG) peptidase inhibition on release of glutamate and dopamine in prefrontal cortex and nucleus accumbens in phencyclidine model of schizophrenia.
Zuo D; Bzdega T; Olszewski RT; Moffett JR; Neale JH
J Biol Chem; 2012 Jun; 287(26):21773-82. PubMed ID: 22570482
[TBL] [Abstract][Full Text] [Related]
9. Effects of a metabotropic glutamate receptor group II agonist LY354740 in animal models of positive schizophrenia symptoms and cognition.
Schlumberger C; Schäfer D; Barberi C; Morè L; Nagel J; Pietraszek M; Schmidt WJ; Danysz W
Behav Pharmacol; 2009 Feb; 20(1):56-66. PubMed ID: 19179851
[TBL] [Abstract][Full Text] [Related]
10. Amygdala regulation of nucleus accumbens dopamine output is governed by the prefrontal cortex.
Jackson ME; Moghaddam B
J Neurosci; 2001 Jan; 21(2):676-81. PubMed ID: 11160446
[TBL] [Abstract][Full Text] [Related]
11. Lack of effect of LY314582 (a group 2 metabotropic glutamate receptor agonist) on phencyclidine-induced locomotor activity in metabotropic glutamate receptor 2 knockout mice.
Spooren WP; Gasparini F; van der Putten H; Koller M; Nakanishi S; Kuhn R
Eur J Pharmacol; 2000 May; 397(1):R1-2. PubMed ID: 10844118
[TBL] [Abstract][Full Text] [Related]
12. Comparison of the mGlu(5) receptor positive allosteric modulator ADX47273 and the mGlu(2/3) receptor agonist LY354740 in tests for antipsychotic-like activity.
Schlumberger C; Pietraszek M; Gravius A; Klein KU; Greco S; Morè L; Danysz W
Eur J Pharmacol; 2009 Nov; 623(1-3):73-83. PubMed ID: 19765575
[TBL] [Abstract][Full Text] [Related]
13. Effects of metabotropic glutamate receptor 2/3 agonism and antagonism on schizophrenia-like cognitive deficits induced by phencyclidine in rats.
Amitai N; Markou A
Eur J Pharmacol; 2010 Aug; 639(1-3):67-80. PubMed ID: 20371228
[TBL] [Abstract][Full Text] [Related]
14. Group II mGluR agonist LY354740 and NAAG peptidase inhibitor effects on prepulse inhibition in PCP and D-amphetamine models of schizophrenia.
Profaci CP; Krolikowski KA; Olszewski RT; Neale JH
Psychopharmacology (Berl); 2011 Jul; 216(2):235-43. PubMed ID: 21327758
[TBL] [Abstract][Full Text] [Related]
15. Different roles of group I and group II metabotropic glutamate receptors on phencyclidine-induced dopamine release in the rat prefrontal cortex.
Maeda J; Suhara T; Okauchi T; Semba J
Neurosci Lett; 2003 Jan; 336(3):171-4. PubMed ID: 12505620
[TBL] [Abstract][Full Text] [Related]
16. Metabotropic glutamate receptor modulation of dopamine release in the nucleus accumbens shell is unaffected by phencyclidine pretreatment: In vitro assessment using fast-scan cyclic voltammetry rat brain slices.
Gupta I; Young AMJ
Brain Res; 2018 May; 1687():155-161. PubMed ID: 29524437
[TBL] [Abstract][Full Text] [Related]
17. LY354740 affects startle responding but not sensorimotor gating or discriminative effects of phencyclidine.
Schreiber R; Lowe D; Voerste A; De Vry J
Eur J Pharmacol; 2000 Jan; 388(2):R3-4. PubMed ID: 10666513
[TBL] [Abstract][Full Text] [Related]
18. Selective action of (-)-2-oxa-4-aminobicyclo[3.1.0]hexane-4,6-dicarboxylate (LY379268), a group II metabotropic glutamate receptor agonist, on basal and phencyclidine-induced dopamine release in the nucleus accumbens shell.
Greenslade RG; Mitchell SN
Neuropharmacology; 2004 Jul; 47(1):1-8. PubMed ID: 15165829
[TBL] [Abstract][Full Text] [Related]
19. Group II mGlu receptor activation suppresses norepinephrine release in the ventral hippocampus and locomotor responses to acute ketamine challenge.
Lorrain DS; Schaffhauser H; Campbell UC; Baccei CS; Correa LD; Rowe B; Rodriguez DE; Anderson JJ; Varney MA; Pinkerton AB; Vernier JM; Bristow LJ
Neuropsychopharmacology; 2003 Sep; 28(9):1622-32. PubMed ID: 12825094
[TBL] [Abstract][Full Text] [Related]
20. In vivo inhibition of veratridine-evoked release of striatal excitatory amino acids by the group II metabotropic glutamate receptor agonist LY354740 in rats.
Battaglia G; Monn JA; Schoepp DD
Neurosci Lett; 1997 Jul; 229(3):161-4. PubMed ID: 9237483
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
